Completed PHASE4 INTERVENTIONAL 2-arm NCT02296255

Effect of HPV Vaccination on Women Aged 25 Years

Effective Surveillance and Impact of HPV Vaccination on Screening for Cervical Cancer in Tuscany

Sponsor: Cancer Prevention and Research Institute, Italy

Interventions Cervarix®, GlaxoSmithKline

Updated 6 times since 2017 Last updated: Nov 19, 2014 Started: Apr 30, 2010 Primary completion: May 31, 2011 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cervical Cancer, this trial is completed. The trial is conducted by Cancer Prevention and Research Institute, Italy and has accumulated 6 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cancer Prevention and Research Institute, Italy
Istituto Toscano Tumori
University of Florence

Data source: Cancer Prevention and Research Institute, Italy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Florence, Italy